Copyright
©The Author(s) 2021.
World J Diabetes. Feb 15, 2021; 12(2): 170-197
Published online Feb 15, 2021. doi: 10.4239/wjd.v12.i2.170
Published online Feb 15, 2021. doi: 10.4239/wjd.v12.i2.170
Subgroups | Studies | Participant | Mean difference | Effect size | ||||
Q test | Mean difference (95%CI) | I2 (%) | Q test | Effect size (95%CI) | I2 (%) | |||
Mode of intervention | ||||||||
Text message | 5 | 469 | 55.331 | -0.591 (-0.892, -0.290)c | 92.771c | 133.957 | -1.377 (-2.503, -0.252)a | 97.014c |
Mobile app | 12 | 1154 | 321.220 | -0.359 (-0.502, -0.215)c | 96.576c | 281.110 | -1.308 (-2.009, -0.607)c | 96.087c |
Interactive telephone | 2 | 170 | 9.069 | -0.782 (-1.172, -0.391)c | 88.974b | 2.226 | -2.600 (-3.243, -1.957)c | 55.074 |
Internet server/computer network | 7 | 1288 | 353.994 | -0.431 (-0.558, -0.304)c | 98.305c | 332.245 | -1.751 (-2.819, -0.684)c | 98.194c |
Website | 14 | 1875 | 843.158 | -0.539 (-0.706, -0.371)c | 98.458c | 696.131 | -1.747 (-2.587, -0.907)c | 98.133c |
Video conference | 2 | 164 | 1.687 | -0.845 (-1.144, -0.546)c | 40.719 | 25.261 | -1.450 (-3.323, 0.424) | 96.041c |
Device or tablet | 5 | 1812 | 332.123 | -0.278 (-0.747, 0.191)c | 98.796c | 162.677 | -0.905 (-1.725, -0.085)a | 97.541c |
Duration of intervention, months | ||||||||
≤ 6 | 6 | 1158 | 222.519 | -0.363 (-0.567, -0.159)c | 97.753c | 239.478 | -1.290 (-2.186, -0.394)b | 97.912c |
6 | 20 | 2234 | 1260.455 | -0.626 (-0.766, -0.486)c | 98.493c | 740.442 | -2.054 (-2.712, -1.396)c | 97.434c |
> 6 | 21 | 2565 | 1173.100 | -0.380 (-0.507, -0.252)c | 98.295c | 674.872 | -1.080 (-1.583, -0.578)c | 97.036c |
Focus of intervention | ||||||||
Biomedical parameters | 16 | 2633 | 1830.624 | -0.687 (-0.821, -0.553)c | 99.181c | 844.645 | -2.406 (-3.174, -1.639)c | 98.224c |
Self-management behaviors | 7 | 334 | 64.189 | -0.360 (-0.805, 0.086) | 90.653c | 139.861 | -0.740 (-1.753, 0.274) | 95.710c |
Biomedical and self-management | 24 | 3965 | 687.693 | -0.348 (-0.442, -0.253)c | 96.655c | 645.659 | -1.171 (-1.583, -0.759)c | 96.438c |
Telemedicine method | ||||||||
Telemonitoring | 19 | 3076 | 1872.902 | -0.553 (-0.662, -0.445)c | 99.039c | 1107.777 | -2.263 (-2.991, -1.534)c | 98.375c |
Tele-education | 12 | 994 | 125.448 | -0.495 (-0.683, -0.307)c | 91.231c | 289.370 | -1.068 (-1.767, -0.368)b | 96.199c |
Telemonitoring and tele-education | 16 | 2862 | 501.993 | -0.391 (-0.542, -0.240)c | 97.012c | 287.276 | -1.002 (-1.415, -0.588)c | 94.779c |
Model of intervention | ||||||||
Behavior change | 28 | 2773 | 629.401 | -0.452 (-0.575, -0.329)c | 95.710c | 596.338 | -1.041 (-1.426, -0.656)c | 95.472c |
Treatment | 13 | 2248 | 1518.194 | -0.589 (-0.725, -0.453)c | 99.210c | 710.693 | -2.386 (-3.249, -1.522)c | 98.312c |
Behavior change and treatment | 6 | 1911 | 448.804 | -0.401 (-0.612, -0.189)c | 98.886c | 332.288 | -1.934 (-3.070, -0.799)c | 98.495c |
Intervention lead | ||||||||
Doctor | 11 | 987 | 522.974 | -0.288 (-0.512, -0.064)a | 98.088c | 391.153 | -0.922 (-1.795, -0.048)a | 97.443c |
Nurse | 15 | 2747 | 868.940 | -0.491 (-0.655, -0.327)c | 98.389c | 474.130 | -1.606 (-2.205, -1.006)c | 97.047c |
Multi-disciplinary | 17 | 2941 | 1237.843 | -0.534 (-0.643, -0.425)c | 98.707c | 852.270 | -2.038 (-2.702, -1.375)c | 98.123c |
Allied health | 4 | 257 | 8.094 | -0.939 (-1.651, -0.227)b | 62.935a | 11.197 | -0.600 (-1.137, -0.062)a | 73.208b |
Dropout rate | ||||||||
0%-9.9% | 20 | 2659 | 779.280 | -0.458 (-0.584, -0.333)c | 97.562c | 571.285 | -1.138 (-1.62, -0.657)c | 96.674c |
10%-19.9% | 16 | 2795 | 709.022 | -0.645 (-0.786, -0.504)c | 97.884c | 740.889 | -2.329 (-3.107, -1.552)c | 97.975c |
20% + | 10 | 994 | 365.413 | -0.297 (-0.472, -0.121)c | 97.537c | 267.256 | -0.902 (-1.632, -0.171)a | 96.632c |
Frequency of intervention | ||||||||
Daily | 19 | 2176 | 996.897 | -0.439 (-0.577, -0.302)c | 98.194c | 593.016 | -1.408 (-1.959, -0.857)c | 96.965c |
< daily to > weekly | 10 | 2005 | 627.889 | -0.307 (-0.462, -0.152)c | 98.567c | 602.249 | -1.452 (-2.300, -0.605)c | 98.506c |
Weekly | 7 | 1095 | 448.790 | -0.791 (-1.167, -0.416)c | 98.663c | 353.155 | -2.340 (-3.576, -1.105)c | 98.301c |
< weekly | 5 | 1162 | 30.212 | -0.835 (-1.068, -0.602)c | 86.760c | 131.622 | -2.423 (-3.943, -0.902)b | 96.961c |
Not mentioned | 6 | 494 | 33.795 | -0.227 (-0.690, 0.237) | 85.205c | 42.744 | -0.360 (-1.010, 0.290) | 88.302c |
Rate of use/engagement | ||||||||
≤ 70% | 5 | 808 | 406.483 | -0.212 (-0.526, 0.102) | 99.016c | 254.620 | -1.060 (-2.422, 0.303) | 98.429c |
> 70% | 8 | 1287 | 150.709 | -0.576 (-0.696, -0.455)c | 95.355c | 204.974 | -2.492 (-3.514, -1.469)c | 96.585c |
Not mentioned | 34 | 4837 | 1782.085 | -0.496 (-0.589, -0.403)c | 98.148c | 1231.652 | -1.361 (-1.771, -0.951)c | 97.321c |
Self-care: Medication adherence | ||||||||
No significant differences | 4 | 557 | 57.285 | -0.268 (-0.459, -0.077)b | 94.763c | 39.413 | -0.650 (-1.254, -0.047)a | 92.388c |
Intervention significantly better | 3 | 541 | 22.004 | -0.265 (-0.677, 0.147) | 90.911c | 60.687 | -0.783 (-1.810, 0.245) | 96.704c |
Not mentioned | 40 | 5834 | 2414.200 | -0.522 (-0.605, -0.44)c | 98.385c | 1538.553 | -1.664 (-2.09, -1.237)c | 97.465c |
Self -care: Disease knowledge | ||||||||
No significant differences | 7 | 685 | 33.269 | -0.025 (-0.169, 0.118) | 81.965c | 39.012 | -0.142 (-0.535, 0.252) | 84.620c |
Intervention significantly better | 2 | 197 | 5.253 | -0.590 (-1.401, 0.222) | 80.963a | 42.653 | -1.220 (-3.543, 1.102) | 97.655c |
Not mentioned | 38 | 6050 | 2399.254 | -0.530 (-0.611, -0.449)c | 98.458c | 1584.253 | -1.802 (-2.234, -1.37)c | 97.655c |
Self-care: Behavior change | ||||||||
No significant differences | 3 | 379 | 0.374 | -0.100 (-0.134, -0.065)c | 0.000 | 10.944 | -0.318 (-0.769, 0.132) | 81.726c |
Intervention significantly better | 4 | 328 | 94.795 | -0.532 (-1.153, 0.090) | 96.835c | 70.276 | -1.145 (-2.347, 0.057) | 95.731c |
Not mentioned | 40 | 6225 | 2477.596 | -0.508 (-0.59, -0.427)c | 98.426c | 1678.368 | -1.656 (-2.079, -1.234)c | 97.676c |
Self-care: Glucose monitoring | ||||||||
No significant differences | 1 | 299 | 0.000 | -0.100 (-0.136, -0.064)c | 0.000 | 0.000 | -0.634 (-0.866, -0.401)c | 0.000 |
Intervention significantly better | 3 | 434 | 103.754 | -0.505 (-0.923, -0.087)a | 98.072c | 31.471 | -1.795 (-2.897, -0.693)c | 93.645c |
Not mentioned | 43 | 6199 | 2441.038 | -0.498 (-0.580, -0.416)c | 98.279c | 1807.229 | -1.527 (-1.942, -1.113)c | 97.676c |
Self-care: Hospital visits needed | ||||||||
No significant differences | 2 | 339 | 29.741 | -0.440 (-0.744, -0.137)b | 96.638c | 0.510 | -2.467 (-2.750, -2.184)c | 0.000 |
Intervention significantly better | 1 | 246 | 0.000 | 0.010 (-0.023, 0.043) | 0.000 | 0.000 | 0.082 (-0.187, 0.351) | 0.000 |
Not mentioned | 44 | 6347 | 2341.454 | -0.505 (-0.586, -0.424)c | 98.164c | 1692.930 | -1.519 (-1.906, -1.133)c | 97.460c |
Self-care: self-efficacy | ||||||||
No significant differences | 6 | 1071 | 90.786 | -0.232 (-0.360, -0.105)c | 94.493c | 71.592 | -0.636 (-1.093, -0.178)b | 93.016c |
Intervention significantly better | 1 | 47 | 0.000 | -0.810 (-1.013, -0.607)c | 0.000 | 0.000 | -2.290 (-3.029, -1.552)c | 0.000 |
Not mentioned | 40 | 5814 | 2311.342 | -0.514 (-0.597, -0.430)c | 98.313c | 1633.909 | -1.638 (-2.077, -1.199)c | 97.613c |
Self-care: nutrition | ||||||||
No significant differences | 4 | 380 | 42.368 | -0.642 (-0.845, -0.440)c | 92.919c | 7.474 | -2.190 (-2.608, -1.772)c | 59.861 |
Not mentioned | 43 | 6552 | 2567.224 | -0.466 (-0.546, -0.387)c | 98.364c | 1785.184 | -1.457 (-1.853, -1.061)c | 97.647c |
Self-care: Exercise | ||||||||
No significant differences | 2 | 132 | 7.605 | -0.641 (-0.943, -0.338)c | 86.850b | 0.209 | -2.427 (-2.877, -1.976)c | 0.000 |
Not mentioned | 45 | 6800 | 2636.871 | -0.477 (-0.554, -0.400)c | 98.331c | 1824.510 | -1.485 (-1.866, -1.104)c | 97.588c |
Racial | ||||||||
Hispanic | 2 | 148 | 2.118 | -0.867 (-1.052, -0.682)c | 52.782 | 0.502 | -2.791 (-3.245, -2.337)c | 0.000 |
Not mentioned | 45 | 6784 | 2560.239 | -0.464 (-0.540, -0.388)c | 98.281c | 1804.224 | -1.471 (-1.85, -1.092)c | 97.561c |
Comorbid disease | ||||||||
Overweight/obese | 4 | 318 | 50.425 | -1.270 (-1.971, -0.568)c | 94.051c | 50.979 | -2.034 (-3.280, -0.788)c | 94.115c |
Hypertension | 1 | 299 | 0.000 | -0.100 (-0.136, -0.064)c | 0.000 | 0.000 | -0.634 (-0.866, -0.401)c | 0.000 |
Not mentioned | 42 | 6315 | 2376.371 | -0.439 (-0.516, -0.361)c | 98.275c | 1787.062 | -1.499 (-1.910, -1.087)c | 97.706c |
- Citation: De Groot J, Wu D, Flynn D, Robertson D, Grant G, Sun J. Efficacy of telemedicine on glycaemic control in patients with type 2 diabetes: A meta-analysis. World J Diabetes 2021; 12(2): 170-197
- URL: https://www.wjgnet.com/1948-9358/full/v12/i2/170.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i2.170